1. US FDA CDER. Guidance for Industry: Dissolution testing of immediate release solid oral dosage forms.
http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm070237.pdf
(1997). Accessed 4 Oct 2011.
2. US FDA CDER. Guidance for Industry: Extended release oral dosage forms: Development, Evaluation and Application of In Vitro/In Vivo Correlations.
http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm070239.pdf
(1997). Accessed 4 Oct 2011.
3. US FDA CDER. Draft guidance: metered dose inhaler (MDI) and dry powder inhaler (DPI) drug products chemistry, manufacturing and controls documentation.
http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm070573.pdf
(1998). Accessed 4 Oct 2011.
4. US FDA CDER. Nasal spray and inhalation solution, suspension, and spray drug products chemistry, manufacturing, and controls documentation.
http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm070575.pdf
(2002). Accessed 4 Oct 2011.
5. Joint EMA and Health Canada Guidance. Pharmaceutical quality of inhalation and nasal products. http://www.hc-sc.gc.ca/dhp-mps/prodpharma/applic-demande/guide-ld/chem/inhalationnas-eng.php (2006);